<?xml version="1.0" encoding="UTF-8"?>
<p>A study in China showed that remdesivir is highly effective in controlling SARS-CoV-2 infection 
 <italic>in vitro</italic> (
 <xref rid="B98" ref-type="bibr">98</xref>). Another study that was recently published involving compassionate-use of remdesivir showed clinical improvement in 68% of patient (36 out of 53) who had severe SARS-CoV-2 infection; 57% were extubated and 47% were discharged (
 <xref rid="B99" ref-type="bibr">99</xref>).
</p>
